AU5970400A - Method for producing plants with increased flavonoid and phenolic compound content - Google Patents

Method for producing plants with increased flavonoid and phenolic compound content Download PDF

Info

Publication number
AU5970400A
AU5970400A AU59704/00A AU5970400A AU5970400A AU 5970400 A AU5970400 A AU 5970400A AU 59704/00 A AU59704/00 A AU 59704/00A AU 5970400 A AU5970400 A AU 5970400A AU 5970400 A AU5970400 A AU 5970400A
Authority
AU
Australia
Prior art keywords
plants
plant
flavonoids
hydroxylase
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59704/00A
Inventor
Karin Herbers
Klaus Kramer
Wilhelm Rademacher
Jurgen Schweden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of AU5970400A publication Critical patent/AU5970400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01HNEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H1/00Processes for modifying genotypes ; Plants characterised by associated natural traits
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9771Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/825Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving pigment biosynthesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782Enzyme inhibitors; Enzyme antagonists
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/86Products or compounds obtained by genetic engineering

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Nutrition Science (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)

Description

Method of producing plants with an elevated content of flavonoids and phenolic compounds 5 The present invention relates to a method of increasing the content of flavonoids and phenolic constituents in plants, wherein a plant is generated, by methods of molecular genetics, in which the activity of the enzyme flavanone 3-hydroxylase is reduced. 10 Moreover, in the method according to the invention, the activity of the enzyme flavanone 3-hydroxylase is reduced fully or partially, permanently or transiently, in the entire plant or in parts of the plant by methods of molecular biology (for example 15 antisense constructs, cosuppression, the expression of specific antibodies or the expression of specific inhibitors). The invention furthermore relates to plants with an elevated content of flavonoids and phenolic constituents, whose enzymatic 20 activity of the enzyme flavanone 3-hydroxylase is reduced. Moreover, the invention relates to the use of plants, generated by the method according to the invention, or parts of these plants as foodstuffs, supplements or for producing curative 25 compositions, health-promoting compositions or tonics (juices, infusions, extracts, fermentation products) for humans and animals, and for the production of cosmetics. A variety of phenolic substances are found in plants, for example 30 caffeic acid, ferulic acid, chlorogenic acid, gallic acid, eugenol, lignans, coumarins, lignin, stilbenes (polydatin, resveratrol), flavonoids (flavones, catechines, flavanones, anthocyanidines, isoflavones), and polymethoxylated flavones. Accordingly, phenols are also generally a constituent of a number 35 of plant-derived foodstuffs and stimulants. Certain phenolic substances are of particular importance since, after having been taken up together with the food, they can exert an antioxidant effect in the human or animal metabolism (Baum, B. 0.; Perun, A. L. Antioxidant efficiency versus structure. Soc. Plast. Engrs 40 Trans 2: 250-257, (1962); Gardner, P.T.; McPhail, D.B.; Duthie, G.G. Electron spin resonance spectroscopic assessment of the antioxidant potential of teas in aqueous and organic media. J. Sci. Food Agric. 76: 257-262, (1997); Rice-Evans, C. A.; Miller, N. J.; Pananga, G. Structure-antioxidant activity relationship of 45 flavonoids and phenolic acids. Free Radic. Biol. Med. 20: 933-956, (1996); Salah, N.; Miller, N. J.; Paganga, G.; Tijburg, L.; Bolwell, G. P.; Rice-Evans, C. Polyphenolic flavonoids as 2 scavenger of aqueous phase radicals and as chain-breaking antioxidants. Arch Biochem Biophys 322: 339-346, (1995); Stryer, L. Biochemistry S. Francisco: Freeman, (1975); Vieira, 0.; Escargueil-Blanc, I.; Meilhac, 0.; Basile, J. P.; Laranjinha, J.; 5 Almeida, L.; Salvayre, R.; Negre-Salvayre, A. Effect of dietary phenolic compounds on apoptosis of human cultured endothelial cells induced by oxidized LDL. Br J Pharmacol 123: 565-573, (1998)). Moreover, polyphenols also have a multiplicity of effects on the cell metabolism. Inter alia, they modulate signal 10 transduction enzymes such as protein kinase C, tyrosine protein kinase and phosphatidylinositol 3-kinase (Agullo, G.; Gamet-payrastre, L.; Manenti, S.; Viala, C.; Remesy, C.; Chap, H.; Payrastre, B. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with 15 tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 53: 1649-1657, (1997); Ferriola, P. C.; Cody, V.; Middleton, E. Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure activity relationship. Biochem Pharmacol 38: 1617-1624, (1989); Cushman, M.; Nagarathman, D.; 20 Burg, D. L.; Geahlen, R. L. Synthesis and protein-tyrosine kinase inhibitory activity of flavonoids analogues. J Meed Chem 34: 798-806, (1991); Hagiwara, M.; Inoue, S.; Tanaka, T.; Nunoki, K.; Ito, M.; Hidaka, H. Differential effects of flavonoids as inhibitors of tyrosine protein kinases and serine/threonin 25 protein kinases. Biochem Pharmacol 37: 2987-2992, (1988)) which down-regulates inducible NO synthase (Kobuchi, H.; Droy-Lefaix, M. T.; Christen, Y.; Packer, L. Ginkgo biloba extract (EGb761): inhibitory effect on nitric oxide production in the macrophage cell line RAW 264.7. Biochem Pharmacol 53: 897-903, (1997)) and 30 regulates the gene expression of, for example, interleucins and adhesion molecules (ICAM-1, VCAM-1) (Kobuchi, H.; Droy-Lefaix, M. T.; Christen, Y.; Packer, L. Ginkgo biloba extract (EGb761): inhibitory effect on nitric oxide production in the macrophage cell line RAW 264.7. Biochem Pharmacol 53:897-903, (1997); Wolle, 35 J.; Hill, R. R.; Ferguson, E.; Devall, L. J.; Trivedi, B. K.; Newton, R. S.; Saxena, U. Selective inhibition of Tumor necrosis Factor-induced vascular cell adhesion molecule-1 gene expression by a novel flavonoid. Lack of effect on transcriptional factor NF-kB. Atherioscler Thromb Vasc Biol 16: 1501-1508, (1996)). It 40 is now accepted that these effects are beneficial for precluding and preventing infarctions, cardiovascular diseases, diabetes, a variety of certain cancers, tumors and other chronic diseases (Bertuglia, S.; Malandrino, S.; Colantuoni, A. Effects of the natural flavonoid delphinidin on diabetic microangiopathy. 45 Arznei-Forsch/Drug Res 45: 481-485, (1995); Griffiths, K.; Adlercreutz, H.; Boyle, P.; Denis, L.; Nicholson, R.I.; Morton, M.S. Nutrition and Cancer Oxford: Isis Medical Media, (1996); 3 Hertog, M. G. L.; Fesrens, E. J. M.; Hollman, P. C. K.; Katan, M. B.; Kromhout, D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study. The Lancet 342: 1007-1011, (1993); Kapiotis, S.; Hermann, M.; Held, I.; 5 Seelos, C.; Ehringer, H.; Gmeiner, B. M. Genistein, the dietary-derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage by atherogenic LDL. Arterioscler Thromb Vasc Biol 17: 2868-74, (1997); Stampfer, M. J.; Hennekens, C. H.; Manson, J. E.; Colditz, G. A.; Rosner, B.; 10 Willet, W. C. Vitamin E consumption and the risk of coronary disease in women. New Engl J Med 328: 1444-1449, (1993); Tijburg, L. B. M.; Mattern, T.; Folts, J. D.; Weisgerber, U. M.; Katan, M. B. Tea flavonoids and cardiovascular diseases: a review. Crit Rev Food Sci Nutr 37: 771-785, (1997); Kirk, E. A.; 15 Sutherland, P.; Wang, S. A.; Chait, A.; LeBoeuf, R. C. Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice. J Nutr 128: 954-9, (1998) - references - ). A series of curative compositions, health-promoting compositions or tonics whose 20 effect is based on their content of phenolic substances is therefore already being obtained from suitable plants (Gerritsen, M. E.; Carley, W. W.; Ranges, G. E.; Shen, C. P.; Phan, S. A.; Ligon, G. F.; Perry, C. A. Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression. Am J Pathol 25 147: 278-292, (1995); Lin, J. K.; Chen, Y. C.; Huang, Y. T.; Lin-Shiau, S. Y. Suppression of protein kinase C and nuclear oncogene expression as possible molecular mechanisms of cancer chemoprevention by apigenin and curcumin. J Cell Biochem Suppl 28-29: 39-48, 1997; Zi, X.; Mukhtar, H.; Agarval, R. Novel cancer 30 chemopreventive effects of a flavonoid antioxidant silymarin: inhibition of mRNA expression of an endogenous tumor promoter TNF alpha. Biochem Biophys Res Comm 239: 334-339, 1997. Furthermore, it is known that certain plant-derived foodstuffs or stimulants prepared from them have a positive effect on various diseases. 35 Resveratrol, which is found in white wine, but in particular in red wine (in addition to other components), for example, acts against infarctions, cardiovascular diseases and cancer (Gehm, B.D.; McAndrews, J.M.; Chien, P.-Y.; Jameson, J.L. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for 40 estrogen receptor. Proc Natl Acad Sci USA 94: 14138-14143, (1997); Jang, M.; Cai, L.; Udeani, G.O.; Slowing, K.V.; Thomas, C.F.; Beecher, C.W.W.; Fong, H.H.S; Farnsworth, N.R.; Kinghorn, A.D.; Mehtha, R.G.; Moon, R.C., Pezzuto, J.M. Cancer chemopreventive activity of resveratrol, a natural product 45 derived from grapes. Science 275: 218-220, (1997). A similar action is also found in substances such as catechin, epicatechin-3-gallate, epigallocatechin and -- 4 epigallocatechin-3-gallate, all of which are found in the leaves of tea (Camellia sinensis). Beverages made with, in particular, unfermented tea leaves (green tea) are health-promoting (Hu, G.; Han, C.; Chen, J. Inhibition of oncogene expression by green tea 5 and (-)-epigallocatechin gallate in mice. Nutr Cancer 24: 203-209; (1995); Scholz, E; Bertram, B. Camellia sinensis (L.) 0. Kuntze. Der Teestrauch [the tea shrub]. Z. Phytotherapie 17: 235-250, (1995); Yu, R.; Jiao, J. J.; Duh, J. L.; Gudehithlu, K.; Tan, T. H.; Kong, A. N. Activation of mitogen-activated protein 10 kinases by green tea polyphenols: potential signaling pathways in the regulation of antioxidant responsive elements-mediated phase II enzyme gene expression. Carcinigenesis 18: 451-456, (1997); Jankun, J.; Selman, S.H.; Swiercz, R. Why drinking green tea could prevent cancer. Nature 387: 561, (1997). Moreover, 15 polymethoxylated flavones from citrus fruit also show a potential antitumor action (Chem, J.; Montanari, A.M.; Widmer, W.W. Two new polymethoxylierte flavone, a class of compounds with potential anticancer activity, isolated from cold pressed dancy tangerine peel oil solids. J Agric Food Chem 45: 364-368, (1997)). 20 It is an object of the present invention to find a simple, inexpensive method of increasing the content of flavonoids and phenolic constituents in crop plants. 25 We have found that this object is achieved, starting from physiological studies on growth regulators from the acylcyclohexanedione group, by genetic engineering methods which are now available, surprisingly, and with the aid of which plants can be generated which are characterized by an elevated content 30 of curative, health-promoting or tonifying constituents. Acylcyclohexanediones such as prohexadione-calcium and trinexapac-ethyl (earlier name: cimectacarb) are employed as bioregulators for inhibiting the longitudinal growth of plants. 35 The reason for their bioregulatory action is that they block the biosynthesis of gibberellins, which promote longitudinal growth. Owing to their structural relationship with 2-oxoglutaric acid, they inhibit certain dioxygenases which require 2-oxoglutaric acid as co-substrate (Rademacher, W, Biochemical effects of plant 40 growth retardants, in: Plant Biochemical Regulators, Gausman, HW (ed.), Marcel Dekker, Inc., New York, pp. 169-200 (1991)). It is known that such compounds also engage in the phenol metabolism and are therefore capable of causing, in a variety of plant species, the production of anthocyanins to be inhibited 45 (Rademacher, W et al., The mode of action of acylcyclohexanediones - a new type of growth retardant, in: Progress in Plant Growth Regulation, Karssen, CM, van Loon, LC, 6 luteoforol, luteoliflavan, apigeniflavan and tricetiflavan, and homogeneous and heterogeneous oligomers and polymers of the abovementioned structurally related substances are produced in higher quantities. 5 Elevated concentrations of the phenols hydroxycinnamic acid (p-coumaric acid, ferulic acid, sinapic acid), salicylic acid or umbelliferone, including the homogeneous and heterogeneous oligomers and polymers formed from them, are found in plants 10 after the enzyme activity of the enzyme flavanone 3-hydroxylase (F3H) has been reduced. Equally the concentration of the chalcones such as, for example, phloretin, and of the stilbenes, such as, for example, resveratrol, increases. 15 Since the enzyme activity of the enzyme flavanone 3-hydroxylase is reduced, the concentration of the glycosides of the flovonoids [sic], of the phenolic compounds, of the chalcones and of the stilbenes is also increased. 20 Starting from these findings and the hypotheses derived therefrom, genetically modified crop plants were generated in which the activities of F3H were reduced fully or partially, permanently or transiently, in the entire plant or in individual plant organs or plant tissues, by means of antisense constructs, 25 so that the content of curative, health-promoting or tonifying substituents was improved in terms of quantity and quality. The method according to the invention for increasing the content of flavonoids and phenolic compounds by expressing flavanone 30 3-hydroxylase in antisense orientation can be applied successfully to the following crop plants, but the method is not restricted to the plants mentioned: grapevines, cherries, tomatoes, plums, sloes, blueberries, strawberries, citrus fruit (such as oranges, grapefruit), pawpaw, red cabbage, broccoli, 35 Brussel sprouts, cacao, kale, carrots, parsley, celeriac/celery, onions, garlic, tea, coffee, hops, soya, oilseed rape, oats, wheat, rye, Aronia melanocarpa, Ginko [sic] biloba. Moreover, the invention relates to plants with an elevated 40 content of flavonoids and phenolic constituents, generated by the method according to the invention and with a reduced enzymatic activity of the enzyme flavanone 3-hydroxylase. As an alternative to generating plants whose flavanone 45 3-hydroxylase activity is reduced with the aid of antisense technology, it is also possible to use other methods of molecular genetics which are known from the literature, such as 7 cosuppression or the expression of specific antibodies, in order to achieve this effect. In addition, the invention relates to the use of plants, 5 generated by the method according to the invention, or of parts of these plants as foodstuffs, food supplements or for producing curative compositions, health-promoting compositions or tonics (juices, infusions, extracts, fermentation products) for humans and animals, and for the production of cosmetics. 10 Surprisingly, it has now been found that plants which have been generated in accordance with the invention, or parts of these plants or products produced from them (teas, extracts, fermentation products, juices and the like) have the following 15 effects: (1) the antioxidant capacity in vitro (Electron Spin Resonance (ESR), LDL oxidation, total antioxidant capacity, NO scavenging) is improved; 20 (2) a modulating effect on enzymes, especially signal transduction enzymes (protein kinase C, tyrosine protein kinase, phosphatidylinositol 3-kinase) is observed; 25 (3) a modulation of redox-sensitive transcriptional factors (NF-kB, AP-1) is induced in endothelial cells, lymphocytes and smooth muscle cells; (4) the regulation of gene expression of target genes involved in 30 the pathogenesis of inflammatory diseases (cytokines IL-1 and IL-8, macrophage chemoattractant protein 1 (MCP-1), adhesion factors ICAM-1 and VCAM-1) is modulated; (5) an antiaggregatory effect is induced; 35 (6) the cholesterol synthesis in hepatocytes is inhibited; (7) antiproliferative/antineoplastic effects exist. 40 Example 1 Cloning the gene of a flavanone 3-hydroxylase from Lycopersicon esculentum Mill.cv. Moneymaker. 45 Ripe tomato fruits of Lycopersicon esculentum Mill.cv. Moneymaker were washed, dried and, using a sterile blade, the pericarp was freed from seeds, central columnella and woody parts. The 8 pericarp (approx. 50 g) was frozen in liquid nitrogen. Then, the material was comminuted in a blender. In a pre-cooled mortar, the comminuted material was treated with 100 ml of homogenization medium and mixed. Then, the suspension was transferred into a 5 centrifuge flask by squeezing it through sterile gauze. Then, 1/10 volume 10% SDS was added and the material was mixed thoroughly. After 10 minutes on ice, one volume of phenol/chloroform was added, and the centrifuge flask was sealed and the contents mixed thoroughly. After centrifugation for 15 10 minutes at 4000 rpm, the supernatant was transferred into a fresh reaction vessel. This was followed by three more phenol/chloroform extractions and one chloroform extraction. Then, 1 volume of 3 M NaAC [sic] and 2.5 volumes of ethanol were added. The nucleic acids were precipitated overnight at -20 0 C. The 15 next morning, the nucleic acids were pelleted for 15 minutes in the refrigerated centrifuge (4*C) at 10,000 rpm. The supernatant was discarded, and the pellet was resuspended in 5-10 ml of cold 3 M NaAc. This washing step was repeated twice. The pellet was washed with 80% ethanol. When completely dry, the pellet was 20 taken up in approx. 0.5 ml of sterile DEPC water, and the RNA concentration was determined photometrically. 20 Rg of total RNA were treated first with 3.3 R1 of 3M sodium acetate solution, 2 p1 of IM magnesium sulfate solution, and the 25 mixture was made up to a final volume of 100 Rl with DEPC water. A microliter of Rnase-free [sic] Dnase [sic] (Boehringer Mannheim) was added to this, and the mixture was incubated for 45 minutes at 370 degrees [sic]. After the enzyme had been removed by extraction by shaking with phenol/chloroform/isoamyl alcohol, the 30 RNA was precipitated with ethanol, and the pellet was taken up in 100 Rl DEPC water. 2.5 Rg of RNA from this solution were transcribed into cDNA using a cDNA kit (Gibco BRL). Using amino acid sequences which were derived from cDNA clones 35 encoding flavanone 3-hydroxylase, conserved regions in the primary sequence were identified (Britsch et al., Eur. J. Biochem. 217, 745-754 (1993), and these acted as the basis for designing degenerated PCR oligonucleotides. Using the peptide sequence SRWPDK (amino acid 147-152 in the Petunia hybrida 40 sequence FL3H PETHY), the 5' oligonucleotide was determined and had the following sequence: 5'-TCI (A/C) G (A/G) TGG CC(A/C/G) GA (C/T) AA (A/G) CC-3. 45 9 The sequence of the oligonucleotide deduced by using the peptide sequence DHQAVV (amino acid 276281 [sic] in the Petunia hybrida sequence FL3H PETHY) was as follows: 5'-CTT CAC ACA (C/G/T) GC (C/T) TG (A/G)TG (A/G)TC-3. 5 The PCR reaction was carried out using the tTth polymerase by Perkin-Elmer, following the manufacturer's instructions. The template used was 1/8 of the cDNA (corresponds to 0.3 Vg of RNA). The PCR program was: 10 30 cycles 94 degrees 4 sec 40 degrees 30 sec 72 degrees 2 min 15 72 degrees 10 min The fragment was cloned into Promega's vector pGEM-T following the manufacturer's instructions. 20 The correctness of the fragment was checked by sequencing. Using the restriction cleavage sites Ncol [sic] and Pstl [sic], which are present in the polylinker of the vector pGEM-T, the PCR fragment was isolated, and the overhangs were made blunt-ended using T4-polymerase. This fragment was cloned into an 25 Smal-(blunt-)cut [sic] vector pBinAR (Hbfgen and Willmitzer, Plant Sci. 66: 221 - 230 (1990)) (see Figure 2). This vector contains the CaMV (cauliflower mosaic virus) 35S promoter (Franck et al., Cell 21: 285 - 294 (1980)) and the termination signal from the octopine synthase gene (Gielen et al., EMBO J. 3: 835 30 846 (1984)). This vector mediates, in plants, a resistance to the antibiotic kanamycin. The resulting DNA constructs contained the PCR fragment in sense and antisense orientation. The antisense construct was employed for generating transgenic plants. 35 Figure 2: Fragment A (529 bp) contains the CaMV 35S promoter (nucleotides 6909 to 7437 of the cauliflower mosaic virus). Fragment B [lacuna] the fragment of the F3H gene in antisense orientation. Fragment C (192 bp) contains the termination signal of the octopine synthase gene. 40 Cloning a larger cDNA fragment of the flavanone 3-hydroxylase from Lycopersicon esculentum Mill.cv. Moneymaker using the 5'RACE system. 45 To exclude that the generation of plants with a reduced mRNA flow equilibrium quantity of F3H is not successful due to the small size of the F3H PCR fragment used in the antisense construct, a 10 second antisense construct using a larger F3H fragment should be generated. The 5'RACE method (system for rapid amplification of cDNA ends) 5 was employed for cloning a larger F3H fragment. Extension of the F3H PCR fragment by means of the 5'RACE method using the 5'RACE system for rapid amplification of cDNA ends, Version 2-0 by Life TechnologiesTM. 10 Total RNA was isolated from ripe tomato fruits of Lycopersicon esculentum Mill.cv. Moneymaker (see above). The cDNA first strand synthesis was carried out using the GSP-1 15 (gene-specific primer) 5'-TTCACCACTGCCTGGTGGTCC-3' following the manufacturer's instructions. Following Rnase [sic] digestion, the cDNA was purified using the GlassMAX spin system by Life TechnologiesTM following the manufacturer's instructions. 20 A cytosine homopolymer was added onto the 3' end of the purified simplex F3H cDNA using the terminal deoxynucleotydil [sic] transferase, following the manufacturer's instructions. The 5'-extended F3H cDNA was amplified using a second 25 gene-specific primer (GSP-2), which binds in the 3' region upstream of the GSP-1 recognition sequence and thus allowed a "nested" PCR to be performed. The 5' primer used was the "5'RACE abrided [sic] anchor primer", which was provided by the manufacturer and which is complementary to the homopolymeric dC 30 tail of the cDNA. The cDNA thus amplified, which was termed F 3 Hextended, was cloned into Promega's vector pGEM-T following the manufacturer's instructions. 35 The identity of the cDNA was confirmed by sequencing. The F 3 Hextended cDNA fragment was isolated using the restriction cleavage sites Ncol [sic] and Pstl [sic] which are present in the 40 polylinker of vector pGEM-T, and the overhangs were converted using T4-polymerase and smooth ends [sic]. This fragment was cloned into an Smal-(blunt-)cut [sic] vector pBinAR (Hdfgen and Willmitzer, 1990) (see Figure 3). This vector contains the CaMV (cauliflower mosaic virus) 35S promoter (Franck et al., 1980) and 45 the termination signal from the octopine synthase gene (Gielen et al., 1984). This vector mediates, in plants, a resistance to the antibiotic kanamycin. The resulting DNA constructs contained the 11 PCR fragment in sense and antisense orientation. The antisense construct was employed for generating transgenic plants. Figure 3: Fragment A (529 bp) contains the CaMV 35S promoter 5 (nucleotides 6909 to 7437 of the cauliflower mosaic virus). Fragment B (lacuna] the fragment of the F3H gene in antisense orientation. Fragment C (192 bp) contains the termination signal of the octopine synthase gene. 10 Example 2 Generation of transgenic Lycopersicon esculentum Mill.cv. Moneymaker which express a subfragment of flavanone 3-hydroxylase in antisense orientation. 15 The method used was that of Ling et al., Plant Cell Report 17, 843 - 847 (1998). Cultivation was carried out at approx. 22 0 C under a 16-hour-light/8-hour-dark regime. 20 Tomato seeds (Lycopersicon esculentum Mill. cv. Moneymaker) were incubated by incubation [sic] for 10 minutes in 4% strength sodium hypochlorite solution, and subsequently washed 3-4 times with sterile distilled water and placed on MS medium supplemented with 3% sucrose, pH 6.1, for germination. After a germination 25 time of 7-10 days, the cotyledons were ready for use in transformation. Day 1: Petri dishes containing "MSBN" medium were overlaid with 1.5 ml of an approximately 10-day-old tobacco suspension culture. 30 The plates were covered with film and incubated at room temperature until the next day. Day 2: Sterile filter paper was placed onto the plates overlaid with the tobacco suspension culture in such a way that no air 35 bubbles were formed. The cotyledons, which had been cut crosswise, were placed on the filter paper upside down. The Petri dishes were incubated for 3 days in a culture chamber. Day 5: The agrobacterial culture (LBA4404) was sedimented by 40 centrifugation for 10 minutes at approx. 3000 g and resuspended in MS medium so that the OD was 0.3. The cotyledon sections were placed into this suspension and incubated for 30 minutes at room temperature with gentle shaking. Then, the cotyledon sections were dried somewhat on sterile filter paper and returned to their 45 starting plates to continue cocultivation for 3 days in the culture chamber.
12 Day 8: The cocultured cotyledon sections were placed on MSZ2K50+B and incubated for the next 4 weeks in the culture chamber. They were then subcultured. 5 Shoots which formed were transferred to root induction medium After successful rooting, the plants were tested and transferred into the greenhouse. 10 Example 3 Inhibition of cholesterol biosynthesis in cultures of primary rat hepatocytes 15 Preparation of the stock solutions Between 10 and 20 mg of the lyophilisate of ripe tomatoes cv."Moneymaker" containing A) only the native flavanone 3-hydroxylase gene (control) and B) as described in Example 2 20 additionally a subfragment of the flavanone 3-hydroxylase in antisense orientation, was weighed exactly and treated with such an amount of DMSO that a stock solution of 10 mM total flavonoids resulted. Immediately before the tests were started, dilutions of these stock solutions in the culture medium were prepared. 25 Ten-fold dilution steps were carried out between 10-4 and 10- 8 M. Preparation of the hepatocyte cultures Primary hepatocytes were obtained from the livers of male 30 Spraque-Dawley [sic] rats (240-290 g) by means of collagenase perfusion (Gebhardt et al., Arzneimittel-Forschung/Drug Res. 41: 800-804 (1991) 1990). The hepatocytes were cultured in collagen-coated Petri dishes (6-well plates, Greiner, NUrtingen) at a cell density of 125,000 cells/cm 2 in Williams Medium E 35 supplemented with 10% calf serum. More details, in particular on the culture medium, are found in Gebhardt et al., Cell Biol. Toxicol. 6: 369 - 372 (1990) and Mewes et al., Cancer Res. 53: 5135 - 5142 (1993). After 2 hours, the cultures were transferred to serum-free medium supplemented with 0.1 RM insulin. After a 40 further 20 hours, they were employed in the tests. The test substances were tested in each case in three independent cultures from 2-3 rats. Incubation of the hepatocyte cultures with the test substances A 45 and B 13 To demonstrate that the cholesterol biosynthesis is affected by the test substances A and B, the hepatocyte cultures were kept for a total of 22 hours. Then, they were incubated with serum-free Williams Medium E supplemented with 14 C acetate (only 5 tracer quantities) for 2 hours together with the test substances at the concentrations indicated. In each test series, a control was included. The methodology is described in detail by Gebhardt (1991) and Gebhardt, Lipids 28: 613-619 (1993). The tracer quantities of 14 C acetate exchange rapidly with the intracellular 10 acetyl-CoA pool and therefore allow the incorporation of 1 4 C acetate into the sterol fraction, which consists of >90% of cholesterol, to be determined in a trouble-free manner (Gebhardt, 1993). 15 Analytical methods for influencing the cholesterol biosynthesis The incorporation of 14 C acetate into the sterol fraction (non-hydrolyzable lipids) was measured by the method of Gebhardt (1991). In the extraction used, in which Extrelut@ columns 20 (Merck, Darmstadt) are employed, over 95% of the 14 C acetate (and small amounts of other low-molecular-weight metabolites formed from it) are removed. This test allows comparisons to be made between the relative synthesis rate of cholesterol and precursor sterols under the effect of test substances (Gebhardt, 1993). 25 Visual and microbial quality checks of the hepatocyte cultures Before and after the test incubation, all the cultures used were checked visually under the microscope for contamination with 30 microorganisms and for the integrity of the cell monolayer. A recognizable change in cell morphology (in particular at the higher concentrations) was not observed in any of the samples. This largely excludes that the test results were affected by cytotoxic effects of the test substances. 35 The routine sterility tests on all cultures revealed no signs of contamination whatsoever with microorganisms. Results 40 Samples A) from the tomatoes which were not genetically modified (control) showed no effect whatsoever on cholesterol biosynthesis. In contrast, the cholesterol synthesis was inhibited significantly by samples B from the tomatoes which 45 contained a subfragment of flavanone 3-hydroxylase in antisense orientation.

Claims (5)

1. A method of increasing the content of flavonoids and phenolic 5 constituents in plants, wherein a plant is generated, by methods of molecular genetics, in which the activity of the enzyme flavanone 3-hydroxylase is reduced.
2. A method as claimed in claim 1 for increasing the content of 10 flavonoids and phenolic constituents in plants, wherein the activity of the enzyme flavanone 3-hydroxylase is reduced fully or partially, permanently or transiently, in the entire plant or in parts of the plant by methods of molecular biology (for example antisense constructs, cosuppression, the 15 expression of specific antibodies or the expression of specific inhibitors).
3. A method as claimed in claim 1 or 2, wherein the plants are grapevines, cherries, tomatoes, plums, sloes, blueberries, 20 strawberries, citrus fruits (such as oranges, grapefruit), pawpaw, red cabbage, broccoli, Brussel sprouts, cacao, kale, carrots, parsley, celeriac/celery, onions, garlic, tea, coffee, hops, soya, oilseed rape, oats, wheat, rye, Aronia melanocarpa, Ginkgo biloba. 25
4. A plant with an elevated content of flavonoids and phenolic constituents generated by a method as claimed in any of claims 1-3, wherein the enzymatic activity of the enzyme flavanone 3-hydroxylase is reduced. 30
5. The use of plants or of parts of these plants, generated by a method as claimed in any of claims 1-3, as foodstuffs, supplements or for producing curative compositions, health-promoting compositions or tonics (juices, teas, 35 extracts, fermentation products) for humans and animals, and for the production of cosmetics. 40 45 15 Method of producing plants with an elevated content of flavonoids and phenolic compounds 5 Abstract In a method for increasing the flavonoid content in plants, a plant is generated by methods of molecular genetics in which the activity of the enzyme flavanone 3-hydroxylase is reduced. 10 15 20 25 30 35 40 45
AU59704/00A 1999-06-17 2000-06-07 Method for producing plants with increased flavonoid and phenolic compound content Abandoned AU5970400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19927574 1999-06-17
DE19927574A DE19927574A1 (en) 1999-06-17 1999-06-17 Increasing content of flavonoids and phenols in plants, useful for e.g. preventing cardiovascular disease, by reducing activity of flavanone-3-hydroxylase
PCT/EP2000/005257 WO2000078980A1 (en) 1999-06-17 2000-06-07 Method for producing plants with increased flavonoid and phenolic compound content

Publications (1)

Publication Number Publication Date
AU5970400A true AU5970400A (en) 2001-01-09

Family

ID=7911499

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59704/00A Abandoned AU5970400A (en) 1999-06-17 2000-06-07 Method for producing plants with increased flavonoid and phenolic compound content

Country Status (16)

Country Link
EP (1) EP1102855A1 (en)
JP (1) JP2003503032A (en)
KR (1) KR20020068256A (en)
CN (1) CN1314943A (en)
AR (1) AR024381A1 (en)
AU (1) AU5970400A (en)
BG (1) BG105246A (en)
BR (1) BR0006869A (en)
CA (1) CA2340319A1 (en)
CO (1) CO5280139A1 (en)
DE (1) DE19927574A1 (en)
HU (1) HUP0103307A2 (en)
IL (1) IL141173A0 (en)
PL (1) PL346059A1 (en)
WO (1) WO2000078980A1 (en)
ZA (1) ZA200101328B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100642939B1 (en) * 2003-02-11 2006-11-10 학교법인 신천학원 Bathroom soap comprising plum extracts and extracting method thereof
WO2005074710A1 (en) * 2004-02-06 2005-08-18 Konkuk University Industrial Coorperation Corp Sprouted bean containing high concentration of isoflavone and the preparing method thereof
KR100553522B1 (en) * 2004-02-06 2006-02-20 학교법인 건국대학교 Isoflavone Fortifying Sprouted Mung Bean and the Method Thereof
KR100663669B1 (en) * 2005-05-18 2007-01-02 금호석유화학 주식회사 Transgenic rice line producing high level of flavonoids in the endosperm
BRPI1006254A2 (en) * 2009-04-21 2016-08-09 Haas John I method for improving the desired performance of a ruminant animal, method for improving the rumen health and functionality of a group of ruminant animals, method for improving the desired performance of a ruminant animal receiving a polyether ionophore antibiotic or macrolide food-containing antibiotic animal
EP2286669A1 (en) * 2009-07-29 2011-02-23 Nestec S.A. Flavanones-containing food compositions
US20140072692A1 (en) * 2012-06-07 2014-03-13 Ichiro Yamada Garlic egg yolk composition
KR101415687B1 (en) * 2012-09-19 2014-07-10 농업회사법인 호트팜 주식회사 Multiple Propagation Methods of in vitro Plantlets Derived from Node Cultures of Aronia using Tissue Culture Techniques
WO2015140589A1 (en) * 2014-03-20 2015-09-24 Hongkong Chuanghui International Limited Method for preparation multifunctional liquid medicament from vegetable feedstock, and the product produced by the method
CN105985936A (en) * 2015-02-02 2016-10-05 中国人民解放军第二军医大学 Erigeron breviscapus flavanone-3-hydroxylase as well as coding gene and application thereof
CN111875689B (en) * 2020-08-07 2022-02-01 山东玄康种业科技有限公司 Method for creating male sterile line by using tomato green stem close linkage marker
EP4206192A1 (en) 2020-08-25 2023-07-05 Otsuka Pharmaceutical Co., Ltd. Kaempferol aglycone-containing extract
CN112391362B (en) * 2020-11-04 2022-07-05 江南大学 Flavone 3 beta-hydroxylase mutant with improved catalytic activity and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5432068A (en) * 1990-06-12 1995-07-11 Pioneer Hi-Bred International, Inc. Control of male fertility using externally inducible promoter sequences
RO116095B1 (en) * 1992-03-09 2000-10-30 Univ Washington Method for the regulation of plant fertility
GB9525459D0 (en) * 1995-12-13 1996-02-14 Zeneca Ltd Genetic control of fruit ripening
BR9909414A (en) * 1998-02-25 2001-01-09 Du Pont Isolated nucleic acid fragment encoding all or a substantial part of a flavanone-3-hydroxylase, chimeric gene, trans-formed host cell, flavanone-3-hydroxylase polypeptide, method of altering the level of expression of a flavanone-3-hydroxylase in a host cell, method of obtaining a nucleic acid fragment encoding all or a substantial part of the amino acid sequence encoding a flavanone-3-hydroxylase, its product and method of evaluating the ability of at least one compound to inhibit activity of a flavanone-3-hydroxylase
AU2687000A (en) * 1999-02-22 2000-09-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Transgenic plants and method for transforming carnations

Also Published As

Publication number Publication date
PL346059A1 (en) 2002-01-14
CN1314943A (en) 2001-09-26
AR024381A1 (en) 2002-10-02
ZA200101328B (en) 2002-02-18
JP2003503032A (en) 2003-01-28
CO5280139A1 (en) 2003-05-30
DE19927574A1 (en) 2000-12-21
WO2000078980A1 (en) 2000-12-28
CA2340319A1 (en) 2000-12-28
EP1102855A1 (en) 2001-05-30
BR0006869A (en) 2001-08-07
BG105246A (en) 2001-10-31
HUP0103307A2 (en) 2001-12-28
IL141173A0 (en) 2002-02-10
KR20020068256A (en) 2002-08-27

Similar Documents

Publication Publication Date Title
Duke et al. Current and potential exploitation of plant glandular trichome productivity
Estrada et al. Pungency level in fruits of the Padrón pepper with different water supply
Karppinen et al. Changes in the abscisic acid levels and related gene expression during fruit development and ripening in bilberry (Vaccinium myrtillus L.)
Kim et al. Analysis of eight phytohormone concentrations, expression levels of ABA biosynthesis genes, and ripening-related transcription factors during fruit development in strawberry
Pandey et al. Development of AtMYB12-expressing transgenic tobacco callus culture for production of rutin with biopesticidal potential
Tajik et al. Induction of phenolic and flavonoid compounds in leaves of saffron (Crocus sativus L.) by salicylic acid
Flores-Sanchez et al. PKS activities and biosynthesis of cannabinoids and flavonoids in Cannabis sativa L. plants
JP2006052217A (en) Method for increasing content of flavonoid and phenolic ingredient in plant
AU5970400A (en) Method for producing plants with increased flavonoid and phenolic compound content
Gagné et al. Leucoanthocyanidin reductase and anthocyanidin reductase gene expression and activity in flowers, young berries and skins of Vitis vinifera L. cv. Cabernet-Sauvignon during development
Boba et al. Methyl salicylate level increase in flax after Fusarium oxysporum infection is associated with phenylpropanoid pathway activation
Wu et al. Two O-methyltransferases isolated from flower petals of Rosa chinensis var. spontanea involved in scent biosynthesis
Li et al. Development of marker-free transgenic potato tubers enriched in caffeoylquinic acids and flavonols
Jadhav et al. Expression analysis of key genes of phenylpropanoid pathway and phenol profiling during Ricinus communis–Fusarium oxysporum f. sp. ricini interaction
Hata et al. Effect of photoperiod on growth of the plants, and sesamin content and CYP81Q1 gene expression in the leaves of sesame (Sesamum indicum L.)
Siebeneichler et al. Changes in the abscisic acid, phenylpropanoids and ascorbic acid metabolism during strawberry fruit growth and ripening
TW202302853A (en) Methods of high production of polyphenols from red lettuces and uses thereof
Castrillón-Arbeláez et al. Secondary metabolism in Amaranthus spp.—a genomic approach to understand its diversity and responsiveness to stress in marginally studied crops with high agronomic potential
Mahmood et al. He-Ne laser seed treatment improves the nutraceutical metabolic pool of Sunflowers and provides better tolerance against water deficit
Kambiranda et al. In depth proteome analysis of ripening muscadine grape berry cv. Carlos reveals proteins associated with flavor and aroma compounds
Ichimura et al. Ethylene production by gynoecium and receptacle is associated with sepal abscission in cut Delphinium flowers
Li et al. Identification and functional characterization of a new flavonoid synthase gene MdFLS1 from apple
Wang et al. Over 1000-fold synergistic boost in Viniferin levels by elicitation of Vitis vinifera cv. Gamay red cell cultures over accumulating phenylalanine
MXPA01001609A (en) Method for producing plants with increased flavonoid and phenolic compound content
Ebrahimi et al. Engineering of secondary metabolites in tissue and cell culture of medicinal plants: an alternative to produce beneficial compounds using bioreactor technologies

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period